Tag: treatment

0 0 0 Comment
Posted in HEADLINES

MacroGenics stock falls after study shows breast-cancer survival rates for drug didn’t surpass standard treatment

MacroGenics Inc. MGNX, -3.20% shares dropped late Tuesday after the biotech drug developer said its breast-cancer treatment didn’t perform as…

0 0 0 Comment
Posted in HEADLINES

Enlivex stock soars to lead premarket gainers after getting OK to start Phase 2b trial of COVID-19 treatment

Shares of Enlivex Therapeutics Ltd. ENLV, -3.97% soared 21.4% toward a five-month high, enough to pace all premarket gainers early…

0 0 0 Comment
Posted in HEADLINES

Sesen Bio’s stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment

Shares of Sesen Bio Inc. SESN, -57.03% was rocked for a more than 75.4% loss on massive volume in afternoon…

0 0 0 Comment
Posted in HEADLINES

NanoVibronix stock triples in very active trading after upbeat report on UTI treatment

Shares of NanoVibronix Inc. NAOV, +248.14% more than tripled in very volatile and active afternoon trading Friday, after the company…

0 0 0 Comment
Posted in HEADLINES

Kadmon’s graft-versus-host treatment gets FDA approval

Kadmon Holdings Inc. KDMN, +20.56% said Friday that Rezurock, its treatment of chronic graft-versus-host disease (cGVHD) in adjusts and pediatric…

0 0 0 Comment
Posted in HEADLINES

Mizuho: Merck withdrawing Keytruda as a gastric cancer treatment won’t impact the stock

Shares of Merck & Co. Inc. MRK, +0.78% were up 0.7% in trading on Friday, the day after the company…

0 0 0 Comment
Posted in HEADLINES

Vir’s stock gains on early results from clinical trials for its hepatitis B treatment candidate

Shares of Vir Biotechnology Inc. VIR, -8.23% gained 3.1% in premarket trading on Friday after the company shared positive data…

0 0 0 Comment
Posted in HEADLINES

Edesa Biotech shares jump 14% premarket after early review of COVID treatment finds it should continue trial

Edesa Biotech Inc. shares EDSA, -2.11% jumped 14% premarket on Friday, after the Canadian biotech, which is listed on Nasdaq,…

0 0 0 Comment
Posted in HEADLINES

Merck enters $1.2 billion agreement to supply U.S. government with potential COVID-19 treatment

Shares of Merck & Co. Inc. MRK, -0.55% rose 0.9% in premarket trading Wednesday, after the drug maker announced a…

0 0 0 Comment
Posted in HEADLINES

U.S. stops distributing Lilly’s COVID-19 antibody therapy in six states, instead recommends Regeneron’s treatment

The U.S. government said this week it is halting distribution of Eli Lilly & Co.’s LLY, +0.62% COVID-19 antibody treatment…

0 0 0 Comment
Posted in HEADLINES

Emergent says experimental COVID-19 treatment failed in Phase 3 trial

Emergent BioSolutions Inc. EBS, -13.40% said Friday that its experimental COVID-19 treatment did not demonstrate a clinical benefit in a…

0 0 0 Comment
Posted in HEADLINES

Biogen shares jump 9% after FDA extends review period for Alzheimer’s treatment

Biogen Inc. shares BIIB, +5.50% rose 9% Friday, after the company said the U.S. Food and Drug Administration has extended…